Graves's most recent trade in Seres Therapeutics Inc was a trade of 6,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2026 | 6,500 | 6,500 | - | - | Stock Option (right to buy) | |
| Harrow Health Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 5,248 | 5,248 | - | - | RSU | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,000 | 64,000 (0%) | 0% | 0 | Common Stock | |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 73.49 per share. | 03 Jun 2026 | 1,481 | 21,731 (0%) | 0% | 73.5 | 108,839 | Common Stock |
| Axcelis Tech Inc | Gregory B. Graves | Director | Sale of securities on an exchange or to another person at price $ 141.40 per share. | 19 May 2026 | 2,625 | 6,073 (0%) | 0% | 141.4 | 371,188 | Common Stock |
| Axcelis Tech Inc | Gregory B. Graves | Director | Sale of securities on an exchange or to another person at price $ 142.52 per share. | 19 May 2026 | 600 | 5,473 (0%) | 0% | 142.5 | 85,509 | Common Stock |
| Harrow Health Inc | Adrienne L. Graves | Director | Purchase of securities on an exchange or from another person at price $ 31.07 per share. | 18 May 2026 | 1,000 | 1,000 (0%) | 0% | 31.1 | 31,070 | Common Stock |
| Axcelis Tech Inc | Gregory B. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 1,440 | 8,698 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Paul W. Graves | Director | Grant, award, or other acquisition of securities at price $ 177.62 per share. | 08 May 2026 | 1,438 | 2,384 (0%) | 0% | 177.6 | 255,418 | Common Stock |
| Integra Lifesciences Holdings Corp | Jeffrey A. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 17,700 | 17,700 | - | - | Restricted Stock Units | |
| UMB Fin Corp | Gregory M. Graves | Director | Grant, award, or other acquisition of securities at price $ 129.24 per share. | 01 May 2026 | 116 | 39,786 (0%) | 0% | 129.2 | 14,992 | Common Stock |
| Opus Genetics Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 24,367 | 127,514 | - | 0 | Common Stock | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 14 Apr 2026 | 30,500 | 1,429,741 (1%) | 0% | 2.0 | 60,390 | Common Stock |
| AutoZone | Earl G. Graves | Director | Sale of securities on an exchange or to another person at price $ 3478.72 per share. | 10 Apr 2026 | 50 | 4,836 (0%) | 0% | 3478.7 | 173,936 | Common Stock |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 01 Apr 2026 | 39,951 | 1,460,241 (1%) | 0% | 1.9 | 74,708 | Common Stock |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2026 | 250,000 | 1,500,192 (1%) | 0% | 0 | Common Stock | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2026 | 250,000 | 250,000 | - | - | Performance Based Restricted Stock Units | |
| Mercury General Corp | Christopher Graves | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2026 | 1,729 | 1,729 | - | - | Restricted Stock Unit | |
| Mercury General Corp | Christopher Graves | See Remarks | Sale or transfer of securities back to the company at price $ 86.45 per share. | 21 Feb 2026 | 979 | 5,400 (0%) | 0% | 86.4 | 84,633 | Common Stock |
| Mercury General Corp | Christopher Graves | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2026 | 979 | 6,379 (0%) | 0% | - | Common Stock | |
| Mercury General Corp | Christopher Graves | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2026 | 979 | 1,958 | - | - | Restricted Stock Unit | |
| Coherent Corp | Lisa Neal-Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 279 | 15,233 (0%) | 0% | 0 | Common Stock | |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 65.83 per share. | 03 Feb 2026 | 326 | 20,250 (0%) | 0% | 65.8 | 21,461 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 127.84 per share. | 02 Feb 2026 | 220 | 39,540 (0%) | 0% | 127.8 | 28,125 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Grant, award, or other acquisition of securities at price $ 127.14 per share. | 30 Jan 2026 | 786 | 39,320 (0%) | 0% | 127.1 | 99,932 | Common Stock |
| FirstCash Holdings Inc | James H. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 833 | 15,679 (0%) | 0% | 0 | Common Stock | |
| Opus Genetics Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 23,643 | 103,147 | - | - | Common Stock | |
| AutoZone | Earl G. Graves | Director | Sale of securities on an exchange or to another person at price $ 3295.00 per share. | 01 Jan 2026 | 250 | 4,886 (0%) | 0% | 3295 | 823,750 | Common Stock |
| AutoZone | Earl G. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 88 | 5,136 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Jeffrey A. Graves | Director | Purchase of securities on an exchange or from another person at price $ 11.35 per share. | 05 Nov 2025 | 9,000 | 41,086 (0%) | 0% | 11.4 | 102,150 | Common Stock |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 59.55 per share. | 03 Nov 2025 | 319 | 19,924 (0%) | 0% | 59.5 | 18,996 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 106.54 per share. | 03 Nov 2025 | 264 | 38,410 (0%) | 0% | 106.5 | 28,126 | Common Stock |
| Thor Ind Inc | Andrew E. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2025 | 1,482 | 24,614 (0%) | 0% | 0 | Common Stock | |
| Hamilton Lane Inc (Class A) | Reynoldo Vann Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2025 | 333 | 1,681 (0%) | 0% | 0 | Class A Common Stock | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.12 per share. | 05 Sep 2025 | 40,125 | 1,250,192 (1%) | 0% | 2.1 | 85,065 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 120.71 per share. | 02 Sep 2025 | 233 | 38,033 (0%) | 0% | 120.7 | 28,125 | Common Stock |
| Coherent Corp | Lisa Neal-Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2025 | 2,272 | 14,954 (0%) | 0% | 0 | Common Stock | |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Sale of securities on an exchange or to another person at price $ 23.75 per share. | 13 Aug 2025 | 50,000 | 104,674 | - | 23.7 | 1,187,340 | Class B Common Shares |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Sale of securities on an exchange or to another person at price $ 23.27 per share. | 12 Aug 2025 | 50,000 | 154,674 | - | 23.3 | 1,163,695 | Class B Common Shares |
| FirstCash Holdings Inc | James H. Graves | Director | Sale of securities on an exchange or to another person at price $ 134.56 per share. | 04 Aug 2025 | 6,000 | 15,846 (0%) | 0% | 134.6 | 807,360 | Common Stock |
| FirstCash Holdings Inc | James H. Graves | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Aug 2025 | 1,000 | 14,846 (0%) | 0% | 0 | Common Stock | |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 60.68 per share. | 04 Aug 2025 | 263 | 19,605 (0%) | 0% | 60.7 | 15,959 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 107.76 per share. | 01 Aug 2025 | 261 | 37,800 (0%) | 0% | 107.8 | 28,125 | Common Stock |
| Harrow Health Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 7,339 | 7,339 | - | - | RSU | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 14,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Paul W. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 2,082 | 2,082 | - | - | Stock Options (Right to Buy) | |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 60.83 per share. | 02 Jun 2025 | 1,606 | 19,342 (0%) | 0% | 60.8 | 97,693 | Common Stock |
| Charles River Labs | Paul W. Graves | Director | Grant, award, or other acquisition of securities at price $ 135.04 per share. | 02 Jun 2025 | 946 | 946 (0%) | 0% | 135.0 | 127,748 | Common Stock |
| Coherent Corp | Lisa Neal-Graves | Director | Sale of securities on an exchange or to another person at price $ 79.65 per share. | 28 May 2025 | 1,200 | 12,682 (0%) | 0% | 79.6 | 95,577 | Common Stock |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Sale of securities on an exchange or to another person at price $ 21.02 per share. | 16 May 2025 | 25,000 | 204,674 | - | 21.0 | 525,500 | Class B Common Shares |
| Axcelis Tech Inc | Gregory B. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 3,586 | 7,258 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Jeffrey A. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 19,592 | 32,086 (0%) | 0% | 0 | Common Stock | |
| Opus Genetics Inc | Graves L. Adrienne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,592 | 79,592 | - | - | Stock Option (Right to Buy) | |
| Opus Genetics Inc | Graves Adrienne L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,504 | 79,504 | - | 0 | Common Stock | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 14 Apr 2025 | 30,626 | 1,290,317 (1%) | 0% | 2.0 | 62,171 | Common Stock |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.07 per share. | 01 Apr 2025 | 247,933 | 1,320,943 (1%) | 0% | 2.1 | 513,221 | Common Stock |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 247,933 | 1,320,943 (1%) | 0% | 0 | Common Stock | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 247,933 | 247,933 | - | - | Performance Based Restricted Stock Units | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Mar 2025 | 18,772 | 1,073,010 (0%) | 0% | 2.7 | 51,435 | Common Stock |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 14 Mar 2025 | 53,256 | 229,674 | - | 20.1 | 1,068,315 | Class B Common Shares |
| SkyWater Tech Inc | Gregory B. Graves | Director | Sale of securities on an exchange or to another person at price $ 8.11 per share. | 14 Mar 2025 | 12,844 | 14,285 | - | 8.1 | 104,165 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 110.29 per share. | 03 Mar 2025 | 255 | 37,288 (0%) | 0% | 110.3 | 28,125 | Common Stock |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 34,575 | 282,930 | - | 0 | Class B Common Shares | |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 29,319 | 248,355 | - | 0 | Class B Common Shares | |
| Coherent Corp | Lisa Neal-Graves | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Feb 2025 | 580 | 13,882 (0%) | 0% | 0 | Common Stock | |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 24 Feb 2025 | 234,038 | 1,566,468 (1%) | 0% | 3.8 | 889,344 | Ordinary Shares |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 234,038 | 0 | - | - | Stock Option (Right to Buy) | |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 24 Feb 2025 | 234,038 | 1,332,430 (0%) | 0% | 5.8 | 1,362,101 | Ordinary Shares |
| Mercury General Corp | Christopher Graves | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 2,937 | 2,937 | - | - | Restricted Stock Unit | |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 668,731 | 1,332,430 (0%) | 0% | 0 | Ordinary Shares | |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 62.75 per share. | 03 Feb 2025 | 215 | 17,736 (0%) | 0% | 62.7 | 13,491 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Grant, award, or other acquisition of securities at price $ 117.90 per share. | 31 Jan 2025 | 678 | 36,922 (0%) | 0% | 117.9 | 79,936 | Common Stock |
| FirstCash Holdings Inc | James H. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 1,263 | 21,846 (0%) | 0% | 0 | Common Stock | |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 18,076 | 175,151 | - | - | Class B Common Shares | |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 10,204 | 10,204 | - | - | 2023 LTIP - Restricted Stock Units | |
| Hamilton Insurance Grp Ltd (Class B) | Megan Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 7,872 | 0 | - | - | 2022 LTIP - Restricted Stock Units | |
| AutoZone | G. Graves Earl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 90 | 5,048 (0%) | 0% | 0 | Common Stock | |
| Arcadium Lithium PLC | W. Graves Paul | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.97 per share. | 20 Dec 2024 | 91,941 | 663,699 (0%) | 0% | 5.0 | 456,947 | Ordinary Shares |
| 3D Systems Corp | Graves Jeffrey A. | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 17 Dec 2024 | 60,000 | 1,091,782 (0%) | 0% | 3.9 | 231,000 | Common Stock |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 3.35 per share. | 11 Nov 2024 | 383,352 | 755,640 (0%) | 0% | 3.4 | 1,285,763 | Ordinary Shares |
| Hamilton Insurance Grp Ltd (Class B) | Graves | CEO, Hamilton Re | 11 Nov 2024 | 33,681 | 157,075 | - | - | Class B Common Shares | ||
| Hamilton Insurance Grp Ltd (Class B) | Graves | CEO, Hamilton Re | 11 Nov 2024 | 33,681 | 33,681 | - | - | Restricted Stock Units | ||
| UMB Fin Corp | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 109.55 per share. | 01 Nov 2024 | 257 | 36,244 (0%) | 0% | 109.6 | 28,155 | Common Stock |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 60.94 per share. | 01 Nov 2024 | 221 | 17,521 (0%) | 0% | 60.9 | 13,468 | Common Stock |
| Opus Genetics Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 172,874 | 172,874 | - | - | Stock Option (right to buy) | |
| Thor Ind Inc | Andrew E. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 1,210 | 23,132 (0%) | 0% | 0 | Common Stock | |
| 3D Systems Corp | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 247,933 | 1,031,782 (0%) | 0% | 0 | Common Stock | |
| Coherent Corp | Lisa Neal-Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 2,831 | 14,462 (0%) | 0% | 0 | Common Stock | |
| Heartland Financial USA Inc | Kathryn Graves Unger | Director | Sale of securities on an exchange or to another person at price $ 49.90 per share. | 02 Aug 2024 | 1,396 | 4,805 (0%) | 0% | 49.9 | 69,662 | Common Stock |
| UMB Fin Corp | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 99.55 per share. | 01 Aug 2024 | 565 | 35,869 (0%) | 0% | 99.6 | 56,247 | Common Stock |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 64.41 per share. | 01 Aug 2024 | 85 | 17,300 (0%) | 0% | 64.4 | 5,475 | Common Stock |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 36,000 (0%) | 0% | 0 | Common Stock | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 64,564 | 64,564 | - | - | Stock Option (right to buy) | |
| Heartland Financial USA Inc | Kathryn Graves Unger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 4,805 | 0 | - | - | 2023 Restricted Stock Units | |
| Heartland Financial USA Inc | Kathryn Graves Unger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 4,805 | 6,201 (0%) | 0% | 0 | Common Stock | |
| Harrow Health Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 8,347 | 8,347 | - | - | RSU | |
| 1st Source Corp | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 50.48 per share. | 03 Jun 2024 | 1,884 | 17,215 (0%) | 0% | 50.5 | 95,104 | Common Stock |